Valued Wealth Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Valued Wealth Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-28	Closed	-$3.24K	–	630
2023 Q4	$3.24K	Buy	+28	New	+$3.25K	﹤0.01%	252

Other funds holding HZNP

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Valued Wealth Advisors's HZNP Position: Q1 2024 in Review

Valued Wealth Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2024, closing a stake of 28 shares — an estimated $3.24K sold.

Valued Wealth Advisors first reported a position in HZNP in Q4 2023 and held it in 1 quarter. The position peaked at $3.24K in Q4 2023. 1 fund tracked by Wall St. Rank holds HZNP as of Q1 2024.

Valued Wealth Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2024 after selling out during the quarter.
Valued Wealth Advisors sold 28 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2024, an estimated $3.24K.
Valued Wealth Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023 and held it in 1 quarter.
Valued Wealth Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.24K in Q4 2023.
1 fund tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2024.

Based on Valued Wealth Advisors's 13F filing for Q1 2024, filed 30 Apr 2024.